Compare Cart
Cover Image
Market Research Report
Product code 
1021139

Chile Radiotherapy Market Size, Share & Trends Analysis Report By Type (External Beam, Internal Beam, Systemic Radiotherapy), By Application (Breast, Prostate, Lung, Colorectal, Head & Neck Cancer), And Segment Forecasts, 2021 - 2028
Published: | Grand View Research, Inc. | 61 Pages | Delivery time: 2-10 business days

Price

Back to Top
Chile Radiotherapy Market Size, Share & Trends Analysis Report By Type (External Beam, Internal Beam, Systemic Radiotherapy), By Application (Breast, Prostate, Lung, Colorectal, Head & Neck Cancer), And Segment Forecasts, 2021 - 2028
Published: July 28, 2021
Grand View Research, Inc.
Content info: 61 Pages
Delivery time: 2-10 business days
  • Description
  • Table of Contents
  • List of Tables

Chile Radiotherapy Market Growth & Trends:

The Chile radiotherapy market size is expected to reach USD 36.0 million by 2028, according to a new study by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.7% from 2021 to 2028. The increasing prevalence of cancer and rising healthcare expenditure are factors expected to propel the growth over the forecast period.

There is a significant gap between the required and installed radiotherapy capacity in Chile. As per a recently published report in the International Journal of Radiation Oncology, Chile had around 41 operative LINACs, which is less than the number required to meet the demand. This provides significant opportunities for growth for the market.

According to the International Agency of Research on Cancer (IARC), the estimated number of new lung cancer cases in Chile was around 4,000 in 2020. The number is expected to reach around 5,500 by 2030. The rising incidence of lung cancer can be attributed to increasing smoking. As per the national health survey, currently, 32.5% of the people in Chile are active smokers. The rising incidence of cancer is expected to drive market growth.

Moreover, companies are adopting strategies that allow them to use their resources to aid in the development of new products and enhance their supply chain. For instance, in August 2020, Siemens Healthcare GmbH announced the acquisition of Varian Medical Systems, Inc. in an all-cash transaction that accounted for USD 16.4 billion. This acquisition may enable the company to offer end-to-end oncology products to address the unmet medical needs of cancer treatment on a global scale.

Chronic adverse effects of radiotherapy occur after months or years of treatment. These effects depend on the total dose of radiotherapy received and the area of treatment. In some regions of the body, radiation treatment can lead to a buildup of body fluids and can cause lymphedema. Radiation exposure to healthy cells in the body can lead to apoptosis, senescence, necrosis, and terminal differentiation of healthy cells, which can lead to death. Radiotherapy weakens the body and can attenuate a body's receptiveness to radiation therapy or surgery. The adverse effects of radiation therapy may restrain market growth.

Chile Radiotherapy Market Report Highlights:

  • In 2020, External Beam Radiation Therapy (EBRT) dominated the market and accounted for the largest revenue share of 86.5%. The high price and high installation base of EBRT equipment is one of the factors for the growth of the segment
  • The internal beam radiation therapy segment is expected to witness a lucrative CAGR of 6.9% during the forecast period. The ability to deliver the precise dose, increased patient preference, and cost-effectiveness are some factors driving the segment
  • The prostate cancer segment dominated the market and accounted for a share of 24.9% in the market in 2020 and is expected to continue its dominance throughout the forecast period. The high incidence and treatment rate of prostate cancer in Chile are some of the factors contributing to its dominance
Product Code: GVR-4-68039-478-0

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation and Scope
    • 1.1.1 Segment scope
    • 1.1.2 Estimates and forecast timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased database:
    • 1.3.2 GVR's internal database
    • 1.3.3 Secondary sources
    • 1.3.4 Primary research
    • 1.3.5 Details of primary research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data analysis models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
  • 1.7 Commodity Flow Analysis
    • 1.7.1 Approach: Commodity Flow Approach
    • 1.7.2 Approach 2: Country-wise market estimation using bottom-up approach
  • 1.8 Global Market: CAGR Calculation
  • 1.9 Research Assumptions
  • 1.10 List of Secondary Sources
  • 1.11 List of Abbreviations
  • 1.12 Objectives
    • 1.12.1 Objective 1
    • 1.12.2 Objective 2
    • 1.12.3 Objective 3
    • 1.12.4 Objective 4

Chapter 2 Executive Summary

  • 2.1 Market Summary

Chapter 3 Industry Outlook

  • 3.1 SWOT Analysis; By Factor (Political & legal, economic, and technological)
  • 3.2 Porter's five forces analysis
  • 3.3 Regulatory Landscape & Reimbursement Scenario
  • 3.4 Market Variable Analysis
    • 3.4.1 Rising adoption of radiotherapy
    • 3.4.2 Technological advancements in radiotherapy
    • 3.4.3 Rising prevalence of cancer
    • 3.4.4 Increase in healthcare expenditure
  • 3.5 Market Restraint & Challenges Analysis
    • 3.5.1 Inadequate radiation infrastructure
    • 3.5.2 Adverse effects of radiotherapy
  • 3.6 Entry Barriers
  • 3.7 Critical Success Factors
  • 3.8 Major Deals and Strategic Alliances
    • 3.8.1 New Product Launches
    • 3.8.2 Mergers and Acquisitions
    • 3.8.3 Research Collaborations
    • 3.8.4 Conferences and Campaigns

Chapter 4 Chile Radiotherapy Market - Segment Analysis, By Type, 2016 - 2028 (USD Million)

  • 4.1 Chile Radiotherapy Market: Type Movement Analysis
  • 4.2 External Beam Radiotherapy
    • 4.2.1 External Beam Radiotherapy Market, 2016 - 2028 (USD Million)
  • 4.3 Internal Beam Radiotherapy
    • 4.3.1 Internal Beam Radiotherapy Market, 2016 - 2028 (USD Million)
  • 4.4 Systemic Radiotherapy
    • 4.4.1 Systemic Radiotherapy Market, 2016 - 2028 (USD Million)

Chapter 5 Chile Radiotherapy Market - Segment Analysis, By Application, 2016 - 2028 (USD Million)

  • 5.1 Chile Radiotherapy Market: Application Movement Analysis
  • 5.2 Prostate cancer
    • 5.2.1 Prostate cancer market, 2016 - 2028 (USD Million)
  • 5.3 Breast cancer
    • 5.3.1 Breast cancer market, 2016 - 2028 (USD Million)
  • 5.4 Lung cancer
    • 5.4.1 Lung cancer market, 2016 - 2028 (USD Million)
  • 5.5 Head and neck cancer
    • 5.5.1 Head and neck cancer market, 2016 - 2028 (USD Million)
  • 5.6 Colorectal cancer
    • 5.6.1 Colorectal cancer market, 2016 - 2028 (USD Million)
  • 5.7 Others
    • 5.7.1 Other Cancers market, 2016 - 2028 (USD Million)

Chapter 6 Chile Radiotherapy Market: Competitive Analysis

  • 6.1 Recent Developments and Impact Analysis, by Key Market Participants
  • 6.2 Vendor Landscape
    • 6.2.1 List of key distributors and channel partners
    • 6.2.2 Key company market share analysis, 2020
  • 6.3 Public Companies
    • 6.3.1 Company market position analysis
    • 6.3.2 Competitive Dashboard Analysis
  • 6.4 Private Companies
    • 6.4.1 List of key emerging companies /technology disruptors/innovators
    • 6.4.2 Regional network map
  • 6.5 Company Profiles
    • 6.5.1 Varian Medical Systems, Inc.
      • 6.5.1.1 Company overview
      • 6.5.1.2 Financial performance
      • 6.5.1.3 Product benchmarking
      • 6.5.1.4 Strategic initiatives
    • 6.5.2 Elekta AB
      • 6.5.2.1 Company overview
      • 6.5.2.2 Financial performance
      • 6.5.2.3 Product benchmarking
      • 6.5.2.4 Strategic initiatives
    • 6.5.3 Accuray Incorporated
      • 6.5.3.1 Company overview
      • 6.5.3.2 Financial performance
      • 6.5.3.3 Product benchmarking
      • 6.5.3.4 Strategic initiatives
    • 6.5.4 Becton, Dickinson and Company
      • 6.5.4.1 Company overview
      • 6.5.4.2 Financial performance
      • 6.5.4.3 Product benchmarking
      • 6.5.4.4 Strategic initiatives
    • 6.5.5 Isoray Medical
      • 6.5.5.1 Company overview
      • 6.5.5.2 Financial performance
      • 6.5.5.3 Product benchmarking
      • 6.5.5.4 Strategic initiatives
    • 6.5.6 NTP Radioisotopes SOC Ltd.
      • 6.5.6.1 Company overview
      • 6.5.6.2 Financial performance
      • 6.5.6.3 Product benchmarking
      • 6.5.6.4 Strategic initiatives

List of Tables

  • TABLE 1 List of secondary sources
  • TABLE 2 List of abbreviations
  • TABLE 3 List of key distributors
  • TABLE 4 List of key emerging companies /technology disruptors/innovators
  • TABLE 5 Chile radiotherapy market, by type, 2016 - 2028 (USD Million)
  • TABLE 6 Chile radiotherapy market, by application, 2016 - 2028 (USD Million)

List of Figures

  • FIG. 1 Chile radiotherapy market segmentation
  • FIG. 2 Market research process
  • FIG. 3 Information procurement
  • FIG. 4 Primary research pattern
  • FIG. 5 Market research approaches
  • FIG. 6 Value-chain-based sizing & forecasting
  • FIG. 7 QFD modeling for market share assessment
  • FIG. 8 Market formulation & validation
  • FIG. 9 Chile radiotherapy market snapshot
  • FIG. 10 SWOT analysis, by factor (political & legal economic and technological)
  • FIG. 11 Porter's five forces analysis
  • FIG. 12 Chile radiotherapy market driver impact
  • FIG. 13 Chile radiotherapy market restraint impact
  • FIG. 14 Critical success factors
  • FIG. 15 Chile radiotherapy market: Type outlook and key takeaways
  • FIG. 16 Chile radiotherapy market: Type movement analysis
  • FIG. 17 External beam radiotherapy market, 2016 - 2028 (USD Million)
  • FIG. 18 Internal beam radiotherapy market, 2016 - 2028 (USD Million)
  • FIG. 19 Systemic radiotherapy market, 2016 - 2028 (USD Million)
  • FIG. 20 Chile radiotherapy market: Application outlook and key takeaways
  • FIG. 21 Chile radiotherapy market: Application movement analysis
  • FIG. 22 Prostate cancer market, 2016 - 2028 (USD Million)
  • FIG. 23 Breast cancer market, 2016 - 2028 (USD Million)
  • FIG. 24 Lung cancer market, 2016 - 2028 (USD Million)
  • FIG. 25 Head and neck cancer market, 2016 - 2028 (USD Million)
  • FIG. 26 Colorectal cancer market, 2016 - 2028 (USD Million)
  • FIG. 27 Other cancers market, 2016 - 2028 (USD Million)
  • FIG. 28 Recent developments and impact analysis, by key market participants
  • FIG. 29 Company market share analysis
  • FIG. 30 Company market position analysis
  • FIG. 31 Company market position analysis
  • FIG. 32 Competitive dashboard analysis
  • FIG. 33 Regional Network Map